IRS1 and breast cancer: Similar to our results, a study has found out that miR-195 inhabited tumor growth and angiogenesis by regulating IRS1 in breast cancer, suggesting that miR-195 might be considered as be a potential therapeutic target in the treatment of breast cancer (Wang et al., 2016).